1-1 of 1
Michael D. Solga
Close
Sort by
Journal Articles

An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20 + cells by rituximab

Adam D. Kennedy, Michael D. Solga, Theodore A. Schuman, Amos W. Chi, Margaret A. Lindorfer, William M. Sutherland, Patricia L. Foley, Ronald P. Taylor
Journal: Blood
Blood (2003) 101 (3): 1071–1079.
https://doi.org/10.1182/blood-2002-03-0876
Published: 2003